ImExHS Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IME.AX research report →
Price Chart
About the company
ImExHS Limited delivers cloud-powered medical imaging technologies to customers worldwide, including those in Australia. The firm specializes in the development and sale of modular imaging software systems, which encompass comprehensive information management platforms for disciplines such as radiology, cardiology, and pathology, alongside a robust picture archiving and communication system (PACS). Its principal software solutions include AQUILA for radiology, ALULA for pathology, and Antero for cardiology.
- CEO
- German Arango
- IPO
- 2005
- Employees
- 290
- HQ
- Sydney, NSW, AU
Get TickerSpark's AI analysis on IME.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $16.86M
- P/E
- -5.20
- Fwd P/E
- 14.76
- PEG
- 0.17
- P/S
- 0.58
- P/B
- 1.06
- EV/EBITDA
- 17.79
- Div Yield
- 0.00%
- Gross Margin
- 36.32%
- Op Margin
- 0.23%
- Net Margin
- -9.95%
- ROE
- -19.01%
- ROIC
- 0.39%
Latest fiscal year · YoY change
- Revenue
- $28.97M+9.0%
- Gross Profit
- $8.31M-24.6%
- Op Income
- $-697,638
- Net Income
- $-2,882,313-9.8%
- EPS
- $-0.06+3.6%
- OCF Growth
- +189.0%
- FCF Growth
- +114.4%
- 52W High
- $0.47
- 52W Low
- $0.22
- 50D MA
- $0.32
- 200D MA
- $0.37
- Beta
- 0.81
- RSI (14)
- 46
- Avg Volume
- 7.30K
No earnings-call transcripts are available for IME.AX yet.
- Free Float
- 96.1%
- Shares Outstanding
- 54.40M
- Float Shares
- 52.25M
Our IME.AX coverage
Recent articles, reports, and earnings notes.
No research on IME.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IME.AX report →